Global MicroRNA (miRNA) Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 78461
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The MicroRNA (miRNA) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global MicroRNA (miRNA) size is estimated to be USD 277.4 million in 2026 from USD 189.1 million in 2020, with a change XX% between 2020 and 2021. The global MicroRNA (miRNA) market size is expected to grow at a CAGR of 10.0% for the next five years.

Market segmentation

MicroRNA (miRNA) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Sample collection

miRNA cDNA Synthesis

Profiling & Purification

Detection

Functional Studies

Market segment by Application, can be divided into

Cancer

Infectious Diseases

Immunological Disorder

Cardiovascular Disease

Neurological Disease

Others

Market segment by players, this report covers

Thermofisher Scientific (Life Technologies)

Agilent Technologies

Merck KGaA

QIAGEN (Exiqon)

NanoString Technologies, Inc.

Dharmacon (Horizon Discovery Group)

Synlogic

GeneCopoeia, Inc.

New England Biolabs

Quantabio

NanoString Technologies, Inc.

BioGenex

SeqMatic LLC

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe MicroRNA (miRNA) product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of MicroRNA (miRNA), with revenue, gross margin and global market share of MicroRNA (miRNA) from 2019 to 2021.

Chapter 3, the MicroRNA (miRNA) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and MicroRNA (miRNA) market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe MicroRNA (miRNA) research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of MicroRNA (miRNA)

1.2 Classification of MicroRNA (miRNA) by Type

1.2.1 Overview: Global MicroRNA (miRNA) Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global MicroRNA (miRNA) Revenue Market Share by Type in 2020

1.2.3 Sample collection

1.2.4 miRNA cDNA Synthesis

1.2.5 Profiling & Purification

1.2.6 Detection

1.2.7 Functional Studies

1.3 Global MicroRNA (miRNA) Market by Application

1.3.1 Overview: Global MicroRNA (miRNA) Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Cancer

1.3.3 Infectious Diseases

1.3.4 Immunological Disorder

1.3.5 Cardiovascular Disease

1.3.6 Neurological Disease

1.3.7 Others

1.4 Global MicroRNA (miRNA) Market Size & Forecast

1.5 Global MicroRNA (miRNA) Market Size and Forecast by Region

1.5.1 Global MicroRNA (miRNA) Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global MicroRNA (miRNA) Market Size by Region, (2016-2021)

1.5.3 North America MicroRNA (miRNA) Market Size and Prospect (2016-2026)

1.5.4 Europe MicroRNA (miRNA) Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific MicroRNA (miRNA) Market Size and Prospect (2016-2026)

1.5.6 South America MicroRNA (miRNA) Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa MicroRNA (miRNA) Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 MicroRNA (miRNA) Market Drivers

1.6.2 MicroRNA (miRNA) Market Restraints

1.6.3 MicroRNA (miRNA) Trends Analysis

2 Company Profiles

2.1 Thermofisher Scientific (Life Technologies)

2.1.1 Thermofisher Scientific (Life Technologies) Details

2.1.2 Thermofisher Scientific (Life Technologies) Major Business

2.1.3 Thermofisher Scientific (Life Technologies) MicroRNA (miRNA) Product and Solutions

2.1.4 Thermofisher Scientific (Life Technologies) MicroRNA (miRNA) Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Thermofisher Scientific (Life Technologies) Recent Developments and Future Plans

2.2 Agilent Technologies

2.2.1 Agilent Technologies Details

2.2.2 Agilent Technologies Major Business

2.2.3 Agilent Technologies MicroRNA (miRNA) Product and Solutions

2.2.4 Agilent Technologies MicroRNA (miRNA) Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Agilent Technologies Recent Developments and Future Plans

2.3 Merck KGaA

2.3.1 Merck KGaA Details

2.3.2 Merck KGaA Major Business

2.3.3 Merck KGaA MicroRNA (miRNA) Product and Solutions

2.3.4 Merck KGaA MicroRNA (miRNA) Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Merck KGaA Recent Developments and Future Plans

2.4 QIAGEN (Exiqon)

2.4.1 QIAGEN (Exiqon) Details

2.4.2 QIAGEN (Exiqon) Major Business

2.4.3 QIAGEN (Exiqon) MicroRNA (miRNA) Product and Solutions

2.4.4 QIAGEN (Exiqon) MicroRNA (miRNA) Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 QIAGEN (Exiqon) Recent Developments and Future Plans

2.5 NanoString Technologies, Inc.

2.5.1 NanoString Technologies, Inc. Details

2.5.2 NanoString Technologies, Inc. Major Business

2.5.3 NanoString Technologies, Inc. MicroRNA (miRNA) Product and Solutions

2.5.4 NanoString Technologies, Inc. MicroRNA (miRNA) Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 NanoString Technologies, Inc. Recent Developments and Future Plans

2.6 Dharmacon (Horizon Discovery Group)

2.6.1 Dharmacon (Horizon Discovery Group) Details

2.6.2 Dharmacon (Horizon Discovery Group) Major Business

2.6.3 Dharmacon (Horizon Discovery Group) MicroRNA (miRNA) Product and Solutions

2.6.4 Dharmacon (Horizon Discovery Group) MicroRNA (miRNA) Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Dharmacon (Horizon Discovery Group) Recent Developments and Future Plans

2.7 Synlogic

2.7.1 Synlogic Details

2.7.2 Synlogic Major Business

2.7.3 Synlogic MicroRNA (miRNA) Product and Solutions

2.7.4 Synlogic MicroRNA (miRNA) Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Synlogic Recent Developments and Future Plans

2.8 GeneCopoeia, Inc.

2.8.1 GeneCopoeia, Inc. Details

2.8.2 GeneCopoeia, Inc. Major Business

2.8.3 GeneCopoeia, Inc. MicroRNA (miRNA) Product and Solutions

2.8.4 GeneCopoeia, Inc. MicroRNA (miRNA) Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 GeneCopoeia, Inc. Recent Developments and Future Plans

2.9 New England Biolabs

2.9.1 New England Biolabs Details

2.9.2 New England Biolabs Major Business

2.9.3 New England Biolabs MicroRNA (miRNA) Product and Solutions

2.9.4 New England Biolabs MicroRNA (miRNA) Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 New England Biolabs Recent Developments and Future Plans

2.10 Quantabio

2.10.1 Quantabio Details

2.10.2 Quantabio Major Business

2.10.3 Quantabio MicroRNA (miRNA) Product and Solutions

2.10.4 Quantabio MicroRNA (miRNA) Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Quantabio Recent Developments and Future Plans

2.11 NanoString Technologies, Inc.

2.11.1 NanoString Technologies, Inc. Details

2.11.2 NanoString Technologies, Inc. Major Business

2.11.3 NanoString Technologies, Inc. MicroRNA (miRNA) Product and Solutions

2.11.4 NanoString Technologies, Inc. MicroRNA (miRNA) Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 NanoString Technologies, Inc. Recent Developments and Future Plans

2.12 BioGenex

2.12.1 BioGenex Details

2.12.2 BioGenex Major Business

2.12.3 BioGenex MicroRNA (miRNA) Product and Solutions

2.12.4 BioGenex MicroRNA (miRNA) Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 BioGenex Recent Developments and Future Plans

2.13 SeqMatic LLC

2.13.1 SeqMatic LLC Details

2.13.2 SeqMatic LLC Major Business

2.13.3 SeqMatic LLC MicroRNA (miRNA) Product and Solutions

2.13.4 SeqMatic LLC MicroRNA (miRNA) Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 SeqMatic LLC Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global MicroRNA (miRNA) Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 MicroRNA (miRNA) Players Market Share

3.2.2 Top 10 MicroRNA (miRNA) Players Market Share

3.2.3 Market Competition Trend

3.3 MicroRNA (miRNA) Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global MicroRNA (miRNA) Revenue and Market Share by Type (2016-2021)

4.2 Global MicroRNA (miRNA) Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global MicroRNA (miRNA) Revenue Market Share by Application (2016-2021)

5.2 MicroRNA (miRNA) Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America MicroRNA (miRNA) Revenue by Type (2016-2026)

6.2 North America MicroRNA (miRNA) Revenue by Application (2016-2026)

6.3 North America MicroRNA (miRNA) Market Size by Country

6.3.1 North America MicroRNA (miRNA) Revenue by Country (2016-2026)

6.3.2 United States MicroRNA (miRNA) Market Size and Forecast (2016-2026)

6.3.3 Canada MicroRNA (miRNA) Market Size and Forecast (2016-2026)

6.3.4 Mexico MicroRNA (miRNA) Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe MicroRNA (miRNA) Revenue by Type (2016-2026)

7.2 Europe MicroRNA (miRNA) Revenue by Application (2016-2026)

7.3 Europe MicroRNA (miRNA) Market Size by Country

7.3.1 Europe MicroRNA (miRNA) Revenue by Country (2016-2026)

7.3.2 Germany MicroRNA (miRNA) Market Size and Forecast (2016-2026)

7.3.3 France MicroRNA (miRNA) Market Size and Forecast (2016-2026)

7.3.4 United Kingdom MicroRNA (miRNA) Market Size and Forecast (2016-2026)

7.3.5 Russia MicroRNA (miRNA) Market Size and Forecast (2016-2026)

7.3.6 Italy MicroRNA (miRNA) Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific MicroRNA (miRNA) Revenue by Type (2016-2026)

8.2 Asia-Pacific MicroRNA (miRNA) Revenue by Application (2016-2026)

8.3 Asia-Pacific MicroRNA (miRNA) Market Size by Region

8.3.1 Asia-Pacific MicroRNA (miRNA) Revenue by Region (2016-2026)

8.3.2 China MicroRNA (miRNA) Market Size and Forecast (2016-2026)

8.3.3 Japan MicroRNA (miRNA) Market Size and Forecast (2016-2026)

8.3.4 South Korea MicroRNA (miRNA) Market Size and Forecast (2016-2026)

8.3.5 India MicroRNA (miRNA) Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia MicroRNA (miRNA) Market Size and Forecast (2016-2026)

8.3.7 Australia MicroRNA (miRNA) Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America MicroRNA (miRNA) Revenue by Type (2016-2026)

9.2 South America MicroRNA (miRNA) Revenue by Application (2016-2026)

9.3 South America MicroRNA (miRNA) Market Size by Country

9.3.1 South America MicroRNA (miRNA) Revenue by Country (2016-2026)

9.3.2 Brazil MicroRNA (miRNA) Market Size and Forecast (2016-2026)

9.3.3 Argentina MicroRNA (miRNA) Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa MicroRNA (miRNA) Revenue by Type (2016-2026)

10.2 Middle East & Africa MicroRNA (miRNA) Revenue by Application (2016-2026)

10.3 Middle East & Africa MicroRNA (miRNA) Market Size by Country

10.3.1 Middle East & Africa MicroRNA (miRNA) Revenue by Country (2016-2026)

10.3.2 Turkey MicroRNA (miRNA) Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia MicroRNA (miRNA) Market Size and Forecast (2016-2026)

10.3.4 UAE MicroRNA (miRNA) Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global MicroRNA (miRNA) Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global MicroRNA (miRNA) Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market MicroRNA (miRNA) Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global MicroRNA (miRNA) Revenue (USD Million) by Region (2016-2021)

Table 5. Global MicroRNA (miRNA) Revenue Market Share by Region (2021-2026)

Table 6. Thermofisher Scientific (Life Technologies) Corporate Information, Head Office, and Major Competitors

Table 7. Thermofisher Scientific (Life Technologies) Major Business

Table 8. Thermofisher Scientific (Life Technologies) MicroRNA (miRNA) Product and Solutions

Table 9. Thermofisher Scientific (Life Technologies) MicroRNA (miRNA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Agilent Technologies Corporate Information, Head Office, and Major Competitors

Table 11. Agilent Technologies Major Business

Table 12. Agilent Technologies MicroRNA (miRNA) Product and Solutions

Table 13. Agilent Technologies MicroRNA (miRNA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Merck KGaA Corporate Information, Head Office, and Major Competitors

Table 15. Merck KGaA Major Business

Table 16. Merck KGaA MicroRNA (miRNA) Product and Solutions

Table 17. Merck KGaA MicroRNA (miRNA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. QIAGEN (Exiqon) Corporate Information, Head Office, and Major Competitors

Table 19. QIAGEN (Exiqon) Major Business

Table 20. QIAGEN (Exiqon) MicroRNA (miRNA) Product and Solutions

Table 21. QIAGEN (Exiqon) MicroRNA (miRNA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. NanoString Technologies, Inc. Corporate Information, Head Office, and Major Competitors

Table 23. NanoString Technologies, Inc. Major Business

Table 24. NanoString Technologies, Inc. MicroRNA (miRNA) Product and Solutions

Table 25. NanoString Technologies, Inc. MicroRNA (miRNA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Dharmacon (Horizon Discovery Group) Corporate Information, Head Office, and Major Competitors

Table 27. Dharmacon (Horizon Discovery Group) Major Business

Table 28. Dharmacon (Horizon Discovery Group) MicroRNA (miRNA) Product and Solutions

Table 29. Dharmacon (Horizon Discovery Group) MicroRNA (miRNA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Synlogic Corporate Information, Head Office, and Major Competitors

Table 31. Synlogic Major Business

Table 32. Synlogic MicroRNA (miRNA) Product and Solutions

Table 33. Synlogic MicroRNA (miRNA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. GeneCopoeia, Inc. Corporate Information, Head Office, and Major Competitors

Table 35. GeneCopoeia, Inc. Major Business

Table 36. GeneCopoeia, Inc. MicroRNA (miRNA) Product and Solutions

Table 37. GeneCopoeia, Inc. MicroRNA (miRNA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. New England Biolabs Corporate Information, Head Office, and Major Competitors

Table 39. New England Biolabs Major Business

Table 40. New England Biolabs MicroRNA (miRNA) Product and Solutions

Table 41. New England Biolabs MicroRNA (miRNA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Quantabio Corporate Information, Head Office, and Major Competitors

Table 43. Quantabio Major Business

Table 44. Quantabio MicroRNA (miRNA) Product and Solutions

Table 45. Quantabio MicroRNA (miRNA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. NanoString Technologies, Inc. Corporate Information, Head Office, and Major Competitors

Table 47. NanoString Technologies, Inc. Major Business

Table 48. NanoString Technologies, Inc. MicroRNA (miRNA) Product and Solutions

Table 49. NanoString Technologies, Inc. MicroRNA (miRNA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. BioGenex Corporate Information, Head Office, and Major Competitors

Table 51. BioGenex Major Business

Table 52. BioGenex MicroRNA (miRNA) Product and Solutions

Table 53. BioGenex MicroRNA (miRNA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. SeqMatic LLC Corporate Information, Head Office, and Major Competitors

Table 55. SeqMatic LLC Major Business

Table 56. SeqMatic LLC MicroRNA (miRNA) Product and Solutions

Table 57. SeqMatic LLC MicroRNA (miRNA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Global MicroRNA (miRNA) Revenue (USD Million) by Players (2019-2021)

Table 59. Global MicroRNA (miRNA) Revenue Share by Players (2019-2021)

Table 60. Breakdown of MicroRNA (miRNA) by Company Type (Tier 1, Tier 2 and Tier 3)

Table 61. MicroRNA (miRNA) Players Head Office, Products and Services Provided

Table 62. MicroRNA (miRNA) Mergers & Acquisitions in the Past Five Years

Table 63. MicroRNA (miRNA) New Entrants and Expansion Plans

Table 64. Global MicroRNA (miRNA) Revenue (USD Million) by Type (2016-2021)

Table 65. Global MicroRNA (miRNA) Revenue Share by Type (2016-2021)

Table 66. Global MicroRNA (miRNA) Revenue Forecast by Type (2021-2026)

Table 67. Global MicroRNA (miRNA) Revenue by Application (2016-2021)

Table 68. Global MicroRNA (miRNA) Revenue Forecast by Application (2021-2026)

Table 69. North America MicroRNA (miRNA) Revenue by Type (2016-2021) & (USD Million)

Table 70. North America MicroRNA (miRNA) Revenue by Type (2021-2026) & (USD Million)

Table 71. North America MicroRNA (miRNA) Revenue by Application (2016-2021) & (USD Million)

Table 72. North America MicroRNA (miRNA) Revenue by Application (2021-2026) & (USD Million)

Table 73. North America MicroRNA (miRNA) Revenue by Country (2016-2021) & (USD Million)

Table 74. North America MicroRNA (miRNA) Revenue by Country (2021-2026) & (USD Million)

Table 75. Europe MicroRNA (miRNA) Revenue by Type (2016-2021) & (USD Million)

Table 76. Europe MicroRNA (miRNA) Revenue by Type (2021-2026) & (USD Million)

Table 77. Europe MicroRNA (miRNA) Revenue by Application (2016-2021) & (USD Million)

Table 78. Europe MicroRNA (miRNA) Revenue by Application (2021-2026) & (USD Million)

Table 79. Europe MicroRNA (miRNA) Revenue by Country (2016-2021) & (USD Million)

Table 80. Europe MicroRNA (miRNA) Revenue by Country (2021-2026) & (USD Million)

Table 81. Asia-Pacific MicroRNA (miRNA) Revenue by Type (2016-2021) & (USD Million)

Table 82. Asia-Pacific MicroRNA (miRNA) Revenue by Type (2021-2026) & (USD Million)

Table 83. Asia-Pacific MicroRNA (miRNA) Revenue by Application (2016-2021) & (USD Million)

Table 84. Asia-Pacific MicroRNA (miRNA) Revenue by Application (2021-2026) & (USD Million)

Table 85. Asia-Pacific MicroRNA (miRNA) Revenue by Region (2016-2021) & (USD Million)

Table 86. Asia-Pacific MicroRNA (miRNA) Revenue by Region (2021-2026) & (USD Million)

Table 87. South America MicroRNA (miRNA) Revenue by Type (2016-2021) & (USD Million)

Table 88. South America MicroRNA (miRNA) Revenue by Type (2021-2026) & (USD Million)

Table 89. South America MicroRNA (miRNA) Revenue by Application (2016-2021) & (USD Million)

Table 90. South America MicroRNA (miRNA) Revenue by Application (2021-2026) & (USD Million)

Table 91. South America MicroRNA (miRNA) Revenue by Country (2016-2021) & (USD Million)

Table 92. South America MicroRNA (miRNA) Revenue by Country (2021-2026) & (USD Million)

Table 93. Middle East & Africa MicroRNA (miRNA) Revenue by Type (2016-2021) & (USD Million)

Table 94. Middle East & Africa MicroRNA (miRNA) Revenue by Type (2021-2026) & (USD Million)

Table 95. Middle East & Africa MicroRNA (miRNA) Revenue by Application (2016-2021) & (USD Million)

Table 96. Middle East & Africa MicroRNA (miRNA) Revenue by Application (2021-2026) & (USD Million)

Table 97. Middle East & Africa MicroRNA (miRNA) Revenue by Country (2016-2021) & (USD Million)

Table 98. Middle East & Africa MicroRNA (miRNA) Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. MicroRNA (miRNA) Picture

Figure 2. Global MicroRNA (miRNA) Revenue Market Share by Type in 2020

Figure 3. Sample collection

Figure 4. miRNA cDNA Synthesis

Figure 5. Profiling & Purification

Figure 6. Detection

Figure 7. Functional Studies

Figure 8. MicroRNA (miRNA) Revenue Market Share by Application in 2020

Figure 9. Cancer Picture

Figure 10. Infectious Diseases Picture

Figure 11. Immunological Disorder Picture

Figure 12. Cardiovascular Disease Picture

Figure 13. Neurological Disease Picture

Figure 14. Others Picture

Figure 15. Global MicroRNA (miRNA) Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 16. Global MicroRNA (miRNA) Revenue and Forecast (2016-2026) & (USD Million)

Figure 17. Global MicroRNA (miRNA) Revenue Market Share by Region (2016-2026)

Figure 18. Global MicroRNA (miRNA) Revenue Market Share by Region in 2020

Figure 19. North America MicroRNA (miRNA) Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Europe MicroRNA (miRNA) Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Asia-Pacific MicroRNA (miRNA) Revenue (USD Million) and Growth Rate (2016-2026)

Figure 22. South America MicroRNA (miRNA) Revenue (USD Million) and Growth Rate (2016-2026)

Figure 23. Middle East and Africa MicroRNA (miRNA) Revenue (USD Million) and Growth Rate (2016-2026)

Figure 24. MicroRNA (miRNA) Market Drivers

Figure 25. MicroRNA (miRNA) Market Restraints

Figure 26. MicroRNA (miRNA) Market Trends

Figure 27. Thermofisher Scientific (Life Technologies) Recent Developments and Future Plans

Figure 28. Agilent Technologies Recent Developments and Future Plans

Figure 29. Merck KGaA Recent Developments and Future Plans

Figure 30. QIAGEN (Exiqon) Recent Developments and Future Plans

Figure 31. NanoString Technologies, Inc. Recent Developments and Future Plans

Figure 32. Dharmacon (Horizon Discovery Group) Recent Developments and Future Plans

Figure 33. Synlogic Recent Developments and Future Plans

Figure 34. GeneCopoeia, Inc. Recent Developments and Future Plans

Figure 35. New England Biolabs Recent Developments and Future Plans

Figure 36. Quantabio Recent Developments and Future Plans

Figure 37. NanoString Technologies, Inc. Recent Developments and Future Plans

Figure 38. BioGenex Recent Developments and Future Plans

Figure 39. SeqMatic LLC Recent Developments and Future Plans

Figure 40. Global MicroRNA (miRNA) Revenue Share by Players in 2020

Figure 41. MicroRNA (miRNA) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 42. Global Top 3 Players MicroRNA (miRNA) Revenue Market Share in 2020

Figure 43. Global Top 10 Players MicroRNA (miRNA) Revenue Market Share in 2020

Figure 44. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 45. Global MicroRNA (miRNA) Revenue Share by Type in 2020

Figure 46. Global MicroRNA (miRNA) Market Share Forecast by Type (2021-2026)

Figure 47. Global MicroRNA (miRNA) Revenue Share by Application in 2020

Figure 48. Global MicroRNA (miRNA) Market Share Forecast by Application (2021-2026)

Figure 49. North America MicroRNA (miRNA) Sales Market Share by Type (2016-2026)

Figure 50. North America MicroRNA (miRNA) Sales Market Share by Application (2016-2026)

Figure 51. North America MicroRNA (miRNA) Revenue Market Share by Country (2016-2026)

Figure 52. United States MicroRNA (miRNA) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Canada MicroRNA (miRNA) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Mexico MicroRNA (miRNA) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Europe MicroRNA (miRNA) Sales Market Share by Type (2016-2026)

Figure 56. Europe MicroRNA (miRNA) Sales Market Share by Application (2016-2026)

Figure 57. Europe MicroRNA (miRNA) Revenue Market Share by Country (2016-2026)

Figure 58. Germany MicroRNA (miRNA) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. France MicroRNA (miRNA) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. United Kingdom MicroRNA (miRNA) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Russia MicroRNA (miRNA) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Italy MicroRNA (miRNA) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Asia-Pacific MicroRNA (miRNA) Sales Market Share by Type (2016-2026)

Figure 64. Asia-Pacific MicroRNA (miRNA) Sales Market Share by Application (2016-2026)

Figure 65. Asia-Pacific MicroRNA (miRNA) Revenue Market Share by Region (2016-2026)

Figure 66. China MicroRNA (miRNA) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Japan MicroRNA (miRNA) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. South Korea MicroRNA (miRNA) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. India MicroRNA (miRNA) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Southeast Asia MicroRNA (miRNA) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Australia MicroRNA (miRNA) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. South America MicroRNA (miRNA) Sales Market Share by Type (2016-2026)

Figure 73. South America MicroRNA (miRNA) Sales Market Share by Application (2016-2026)

Figure 74. South America MicroRNA (miRNA) Revenue Market Share by Country (2016-2026)

Figure 75. Brazil MicroRNA (miRNA) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Argentina MicroRNA (miRNA) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Middle East and Africa MicroRNA (miRNA) Sales Market Share by Type (2016-2026)

Figure 78. Middle East and Africa MicroRNA (miRNA) Sales Market Share by Application (2016-2026)

Figure 79. Middle East and Africa MicroRNA (miRNA) Revenue Market Share by Country (2016-2026)

Figure 80. Turkey MicroRNA (miRNA) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. Saudi Arabia MicroRNA (miRNA) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. UAE MicroRNA (miRNA) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 83. Methodology

Figure 84. Research Process and Data Source